These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36857361)

  • 41. Impact of anemia on clinical outcomes of patients with atrial fibrillation: The COOL-AF registry.
    Krittayaphong R; Pumprueg S; Thongsri T; Wiwatworapan W; Choochunklin T; Kaewkumdee P; Yindeengam A;
    Clin Cardiol; 2021 Mar; 44(3):415-423. PubMed ID: 33538035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.
    Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GY
    Europace; 2016 May; 18(5):648-57. PubMed ID: 26826133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry.
    Krittayaphong R; Pumprueg S; Ratanasumawong K; Sairat P; Lip GYH;
    Clin Interv Aging; 2021; 16():1835-1846. PubMed ID: 34675498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patients With Atrial Fibrillation Who Are Not on Anticoagulant Treatment Due to Increased Bleeding Risk Are Common and Have a High Risk of Stroke.
    Redfors B; Gray WA; Lee RJ; Ellenbogen KA; Bonafede M; Ben-Yehuda O
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1369-1376. PubMed ID: 29759666
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical care.
    Kirchhof P; Pecen L; Bakhai A; de Asmundis C; de Groot JR; Deharo JC; Kelly P; Levy P; Lopez-de-Sa E; Monteiro P; Steffel J; Waltenberger J; Weiss TW; Laeis P; Manu MC; Souza J; De Caterina R
    Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 9(1):47-57. PubMed ID: 35881467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Cumulative Incidence of Stroke, Myocardial infarction, Heart Failure and Sudden Cardiac Death in Patients with Atrial Fibrillation.
    Naser N; Kulic M; Dilic M; Dzubur A; Durak A; Pepic E; Smajic E; Kusljugic Z
    Med Arch; 2017 Oct; 71(5):316-319. PubMed ID: 29284897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation.
    Kim D; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
    Stroke; 2022 Jun; 53(6):1873-1882. PubMed ID: 35109686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age-Dependent Anticoagulant Therapy for Atrial Fibrillation Patients with Intermediate Risk of Ischemic Stroke: A Nationwide Population-Based Study.
    Choi SY; Kim MH; Lee KM; Cho YR; Park JS; Yun SC; Lip GYH
    Thromb Haemost; 2021 Sep; 121(9):1151-1160. PubMed ID: 33307565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.
    Benavente O; Hart R; Koudstaal P; Laupacis A; McBride R
    Cochrane Database Syst Rev; 2000; (2):CD001927. PubMed ID: 10796453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety outcomes of patients with atrial fibrillation compared between warfarin and non-vitamin K antagonist oral anticoagulants based on SAMe-TT
    Methavigul K; Yindeengam A; Krittayaphong R
    BMC Cardiovasc Disord; 2023 Jan; 23(1):43. PubMed ID: 36690928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan　- Findings From the AF Frontier Ablation Registry.
    Okumura Y; Nagashima K; Arai M; Watanabe R; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Shimizu W; Iwasaki YK; Hayashi H; Harada T; Nakajima I; Okumura K; Koyama J; Tokuda M; Yamane T; Momiyama Y; Tanimoto K; Soejima K; Nonoguchi N; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Satomi K; Yazaki Y; Watari Y;
    Circ J; 2019 Nov; 83(12):2418-2427. PubMed ID: 31619591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry.
    Huisman MV; Rothman KJ; Paquette M; Teutsch C; Diener HC; Dubner SJ; Halperin JL; Ma CS; Zint K; Elsaesser A; Lu S; Bartels DB; Lip GYH;
    Am Heart J; 2018 Apr; 198():55-63. PubMed ID: 29653649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticoagulant Therapy in Initially Low-Risk Patients With Nonvalvular Atrial Fibrillation Who Develop Risk Factors.
    Choi SY; Kim MH; Lee KM; Cho YR; Park JS; Kim SW; Kim JK; Chung M; Yun SC; Lip GYH
    J Am Heart Assoc; 2020 Aug; 9(16):e016271. PubMed ID: 32779499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry.
    Hamatani Y; Yamashita Y; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GY; Akao M
    PLoS One; 2015; 10(11):e0142394. PubMed ID: 26540107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort Study.
    Dawwas GK; Dietrich E; Cuker A; Barnes GD; Leonard CE; Lewis JD
    Ann Intern Med; 2021 Jul; 174(7):910-919. PubMed ID: 33780291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study.
    Dalgaard F; Pieper K; Verheugt F; Camm AJ; Fox KA; Kakkar AK; Pallisgaard JL; Rasmussen PV; Weert HV; Lindhardt TB; Torp-Pedersen C; Gislason GH; Ruwald MH; Harskamp RE
    BMJ Open; 2019 Nov; 9(11):e033283. PubMed ID: 31719095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical characteristics of hemodialysis patients with atrial fibrillation: The RAKUEN (Registry of atrial fibrillation in chronic kidney disease under hemodialysis from Niigata) study.
    Mitsuma W; Matsubara T; Hatada K; Imai S; Saito N; Shimada H; Miyazaki S
    J Cardiol; 2016 Aug; 68(2):148-55. PubMed ID: 26527113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low Body Weight Increases the Risk of Ischemic Stroke and Major Bleeding in Atrial Fibrillation: The COOL-AF Registry.
    Krittayaphong R; Chichareon P; Komoltri C; Kornbongkotmas S; Yindeengam A; Lip GYH
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32842610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation　- A Nationwide Cohort Study.
    Jung H; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Sung JH; Pak HN; Lee MH; Lip GYH; Joung B
    Circ J; 2019 Nov; 83(12):2547-2554. PubMed ID: 31619594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.